Insulin administration: a guide for nursing students

Insulin is a high-alert medication — one of the leading causes of preventable harm in hospitalized patients. For nursing students, mastering insulin administration means understanding the pharmacology, executing the injection technique correctly, and knowing how to recognize and treat the complications that follow when something goes wrong.

This guide covers the full scope of what nurses need to know: insulin types and timing, subcutaneous injection technique, site rotation, mixing rules, sliding scale vs basal-bolus regimens, and the 15-15 hypoglycemia protocol.

Quick reference — insulin at a glance:

• Rapid-acting: give with meals (onset 15 min)
• Short-acting (regular): give 30 min before meals (onset 30–60 min)
• NPH: cloudy appearance — normal; can mix with regular (clear before cloudy)
• Long-acting (glargine, detemir, degludec): never mix with other insulins
• Only regular insulin can be given IV
• Hypoglycemia (BG < 70): 15g carbs → recheck in 15 min

Insulin as a high-alert medication

The Institute for Safe Medication Practices (ISMP) lists insulin among the top high-alert medications in both hospital and community settings. Errors — wrong type, wrong dose, wrong timing, wrong patient — carry a high risk of serious harm. Most facilities require an independent double-check before administering insulin: two nurses verify the drug, dose, type, patient identity, and route separately before either signs off.

For nursing students, this context matters before a single drop is drawn up. Insulin administration is not a routine injection. It requires systematic verification at every step. Understanding safe medication administration and the 6 rights of medication administration is foundational before approaching any insulin dose.

Insulin types: onset, peak, and duration

Insulin pharmacology is one of the highest-yield NCLEX topics in endocrine nursing. The four categories differ in how quickly they start working, when they reach peak effect, and how long they last. These differences drive everything: which insulin gets given when, how to time meals, and what kind of hypoglycemia risk the patient carries at different points in the day.

Insulin is classified under drug classifications nursing as a pancreatic hormone and antidiabetic agent. The broader context of diabetes mellitus nursing — including pathophysiology and glucose regulation — provides the framework for understanding why these timing differences matter clinically.

NCLEX tip: Regular insulin is the ONLY insulin that can be given intravenously. Rapid-acting analogs (lispro, aspart, glulisine) are subcutaneous only.

The mixing rule: clear before cloudy

When a patient requires both regular (short-acting) and NPH (intermediate-acting) insulin in the same injection, the two can be drawn into a single syringe — but the order matters.

The rule: draw clear before cloudy.

1. Inject air into the NPH (cloudy) vial first — do not withdraw insulin yet
2. Inject air into the regular (clear) vial, then withdraw the regular insulin dose
3. Return to the NPH vial and withdraw the NPH dose

The reason: if you draw NPH first and then enter the regular vial, NPH particles contaminate the regular vial. This alters the pharmacokinetics of all future doses drawn from that vial. Drawing clear (regular) first protects the regular vial from contamination.

Long-acting insulins cannot be mixed — ever. Glargine, detemir, and degludec are formulated at specific pH levels that, when mixed with other insulins, alter their absorption profile and destroy their peakless, extended-release behavior. Always give them in a separate injection, in a separate syringe, at a separate site.

NCLEX tip: Clear before cloudy is the mnemonic. NPH can mix with regular. Long-acting insulins (glargine, detemir, degludec) cannot be mixed with anything.

Subcutaneous injection technique

Correct subcutaneous technique ensures predictable insulin absorption. Errors in angle, site, or post-injection handling can significantly alter how quickly — or how much — insulin enters the bloodstream.

Step-by-step procedure:

1. Verify the 6 rights — right patient, right drug, right dose, right route, right time, right documentation. For insulin, also verify the type (rapid vs regular vs long-acting). Confirm the independent double-check is complete per facility policy.
2. Check blood glucose before administering. Withhold insulin and notify the provider if BG is below the facility threshold (typically < 70 mg/dL) or if the patient is NPO unexpectedly.
3. Inspect the insulin — verify correct type, check expiration date, inspect for particulates or discoloration. NPH will appear cloudy (normal). Regular, rapid-acting, and long-acting insulins should be clear. Discard any insulin that is discolored, clumped, or precipitated.
4. Select the injection site — rotate within the same anatomical region. Document the site used.
5. Cleanse the site with an alcohol swab. Allow to dry completely before injecting — wet alcohol stings and may alter skin integrity.
6. Prepare the skin — pinch skin gently if the patient is thin or has minimal subcutaneous tissue.
7. Insert the needle at 90° for most patients. Use a 45° angle for thin or lean patients with minimal subcutaneous fat, to avoid inadvertent intramuscular injection.
8. Inject slowly — depress the plunger steadily. After the full dose is delivered, hold the needle in place for 5–10 seconds before withdrawing. This allows the dose to disperse and prevents leakage back through the needle track.
9. Withdraw in the same angle as insertion. Do NOT massage the injection site — massaging alters the absorption rate and undermines the predictability of the dose.
10. For insulin pens — prime the pen before each injection (dial 2 units, point up, release to expel air and confirm flow). After injecting the full dose, hold the needle in the skin for at least 10 seconds before removing. Never share pens between patients.

Injection site rotation

The body absorbs insulin at different rates from different anatomical sites. Consistent site rotation within one anatomical area — rather than rotating randomly across all areas — gives more predictable pharmacokinetics.

Lipohypertrophy — lumpy, fatty nodules under the skin — develops when patients inject repeatedly into the same spot without rotating. Insulin absorption from lipohypertrophic tissue is unpredictable and often reduced. Inspect injection sites at every visit and educate patients to rotate systematically.

NCLEX tip: Fastest absorption site is the abdomen. Slowest is the buttock. Exercise increases absorption from the thigh and extremities — a patient who exercises after an injection may experience unexpected hypoglycemia.

Insulin regimens: sliding scale vs basal-bolus

Nurses encounter two primary insulin regimens in inpatient settings. Understanding the difference — and the clinical reasoning behind each — is essential for safe administration and patient education.

Sliding scale insulin was once standard practice but is now recognized as suboptimal for most inpatients. A patient on SSI alone receives no insulin during the overnight fast, accumulates hyperglycemia overnight, and then receives a large correction dose in the morning — a cycle that delays recovery, impairs wound healing, and increases infection risk. Basal-bolus regimens avoid this by maintaining background coverage throughout the day and night.

Nurses do not prescribe regimens, but understanding the difference allows them to ask appropriate clarifying questions when orders seem inconsistent — and to educate patients on why their regimen was chosen.

Hypoglycemia: the 15-15 rule

Hypoglycemia is the most immediate complication of insulin administration. A blood glucose below 70 mg/dL requires prompt treatment — delayed treatment can progress to seizure, loss of consciousness, and irreversible brain injury. Monitoring vital signs is essential, as tachycardia and diaphoresis are early adrenergic warning signs of hypoglycemia.

Recognize hypoglycemia in two symptom clusters:

• Adrenergic (early): diaphoresis, tremors, shakiness, anxiety, tachycardia, pallor, hunger
• Neuroglycopenic (later): confusion, blurred vision, headache, slurred speech, difficulty concentrating, loss of consciousness

NCLEX tip: Adrenergic symptoms appear first (epinephrine response). Neuroglycopenic symptoms follow as the brain is deprived of glucose. Patients on beta-blockers may not show adrenergic symptoms — neuroglycopenic signs may be the first warning.

Treatment — the 15-15 rule:

1. Confirm BG < 70 mg/dL
2. If conscious and able to swallow: give 15g of fast-acting carbohydrates
   • 4 oz (120 mL) of fruit juice or regular (not diet) soda
   • 3–4 glucose tablets
   • 1 tablespoon of honey or sugar
3. Recheck blood glucose in 15 minutes
4. If BG remains < 70: repeat 15g carbohydrates and recheck again in 15 minutes
5. Once BG > 70: give a snack with protein and complex carbohydrates to sustain the correction
6. Notify the provider and document the event

Severe hypoglycemia (unconscious or unable to swallow):

• With IV access: 25g dextrose (50 mL of D50W) IV push, or 100–250 mL of D10W
• Without IV access: 1 mg glucagon IM or SC (deltoid or outer thigh); place patient in recovery position; may take 10–15 minutes to work
• Once conscious: oral carbohydrates and a complex snack; assess for cause

Nursing priorities after a hypoglycemic event:

• Identify the likely cause (missed meal, excess dose, unexpected exercise, renal impairment)
• Notify the provider — dose adjustment may be needed
• Document BG values, treatment given, patient response, and provider notification
• Assess for injury if the patient fell or lost consciousness

Somogyi effect vs Dawn phenomenon

Both involve morning hyperglycemia — a common NCLEX distinguishing question.

Somogyi effect: Nocturnal hypoglycemia triggers a counter-regulatory hormone surge (glucagon, cortisol, epinephrine) that causes rebound hyperglycemia by morning. The patient woke up hypoglycemic, and the body overcompensated. Treatment: reduce evening insulin dose or add a bedtime snack.

Dawn phenomenon: Morning hyperglycemia caused by a natural overnight surge in growth hormone and cortisol (occurring between 2–8 a.m.) without preceding hypoglycemia. The patient’s fasting BG rises without any nocturnal low. Treatment: increase the evening or morning insulin dose (or adjust pump basal rate).

How to distinguish them: Check blood glucose at 3 a.m. If BG is low at 3 a.m. → Somogyi effect. If BG is normal or elevated at 3 a.m. → Dawn phenomenon.

Insulin storage and handling

Correct storage protects insulin potency and patient safety.

Unopened insulin:

• Refrigerate at 36–46°F (2–8°C)
• Do NOT freeze — frozen insulin is denatured and must be discarded
• Do NOT expose to direct sunlight or temperatures above 80°F (27°C)

In-use insulin (opened vials or pens):

• Most formulations can be stored at room temperature for 28 days after opening
• Some formulations (e.g., Levemir pens) are labeled for 42 days — always check the package insert
• Mark the date of opening on the vial or pen cap
• Discard after the manufacturer’s room-temperature expiration window, regardless of remaining volume

Insulin pen safety:

• Insulin pens are single-patient use only — never use one pen on more than one patient, even if the needle is changed
• Sharing pens poses a bloodborne pathogen transmission risk and violates Joint Commission standards
• Remove and dispose of the needle immediately after each injection; never store the pen with a needle attached (risk of air entering the cartridge and dose error)

Before each use — inspect the insulin:

• Regular, rapid-acting, and long-acting insulins: should appear clear and colorless
• NPH: should appear uniformly cloudy after rolling (not shaking) — any clumping, crystallization, or frosted appearance indicates degradation; discard
• Any insulin with visible particulates, unusual discoloration, or past expiration: discard immediately

Insulin pumps: basics for nurses

Continuous subcutaneous insulin infusion (CSII) — commonly called an insulin pump — delivers a programmed basal rate of rapid-acting insulin 24 hours a day, with patient-triggered boluses at mealtimes. Pumps use only rapid-acting insulin (lispro, aspart, or glulisine) and approximate physiologic secretion more closely than injection regimens.

Nursing considerations for pump patients:

• Site changes: Infusion cannulas are changed every 48–72 hours. Leaving a site in longer increases infection risk and absorption variability. Document the site location.
• BG monitoring: Pumps do not measure glucose — patients still need to check BG before meals and at bedtime, and more frequently when sick or when BG patterns shift unexpectedly.
• Do not disconnect during illness: Patients often think they should remove the pump when not eating. They should not — basal insulin coverage is needed continuously, especially when sick and at risk for DKA.
• Occlusion signs: If BG rises unexpectedly without explanation, consider cannula occlusion, kinking, or site failure. Check the site, prime the tubing, and change the site if in doubt.
• Hyperglycemic crisis: A pump failure without backup injection can precipitate DKA rapidly in type 1 diabetes, since there is no long-acting insulin on board. Always ensure the patient has a backup pen or vial available.
• Hyperosmolar states: In type 2 patients with pump therapy, prolonged hyperglycemia without ketosis can lead to hyperosmolar hyperglycemic state (HHS) — a less acute but equally dangerous complication.

For patients admitted to hospital with their own pump, facilities have varying policies — some require patients to self-manage under nursing supervision; others suspend the pump and switch to IV or subcutaneous regimens. Know your facility policy.

NCLEX high-yield tips

1. Regular insulin is the only insulin that can be given IV. Rapid-acting analogs (lispro, aspart, glulisine) are subcutaneous only.
2. Clear before cloudy when mixing regular + NPH. Draw regular (clear) first to prevent contaminating the regular vial with NPH.
3. Long-acting insulins (glargine, detemir, degludec) cannot be mixed with any other insulin. Give in a separate syringe at a separate site.
4. NPH insulin appears cloudy — this is normal and does not indicate spoilage. It should be gently rolled, not shaken, before drawing.
5. Fastest insulin absorption site: abdomen. Slowest: buttock. Absorption order: abdomen > arm > thigh > buttock.
6. Do NOT massage after subcutaneous insulin injection. Massaging alters the absorption rate and makes dosing unpredictable.
7. Hypoglycemia = BG < 70 mg/dL. Treat with 15g fast-acting carbohydrates, recheck BG in 15 minutes (the 15-15 rule).
8. Severe hypoglycemia + no IV access = glucagon IM or SC. D50W IV push is the alternative when IV access is available.
9. Never share insulin pens between patients — even if the needle is changed. This violates bloodborne pathogen standards and Joint Commission policy.
10. Insulin pens: prime before each injection (2-unit air purge) and hold the needle in the skin for 10 seconds after the full dose is delivered.
11. Somogyi effect: Nocturnal hypoglycemia → rebound morning hyperglycemia (check 3 a.m. BG — it will be low). Dawn phenomenon: morning hyperglycemia without prior nocturnal low (check 3 a.m. BG — it will be normal or elevated).
12. Regular insulin onset is 30–60 minutes — it must be given 30 minutes before the meal, not with the meal.
13. Rapid-acting insulin (lispro, aspart, glulisine) must be given with meals — food must be present before injecting. Do not give if the patient is refusing to eat or is NPO.
14. Insulin is a high-alert medication. Most facilities require an independent double-check (two nurses verify separately) before administration.
15. Sliding scale insulin is reactive (corrects existing high BG). Basal-bolus is proactive (mimics physiologic insulin secretion). Basal-bolus is the preferred inpatient regimen per ADA guidelines.
16. Patients on beta-blockers may not show adrenergic hypoglycemia symptoms (no tachycardia, no sweating). Neuroglycopenic symptoms (confusion, altered mental status) may be the first sign — monitor BG closely.
17. Insulin pens: store without a needle attached after use. A needle left on the pen allows air to enter the cartridge, which causes inaccurate dosing.

Patient education before discharge

Discharge teaching for insulin-dependent patients is a high-priority nursing responsibility. A patient who understands their regimen is far less likely to present to the emergency department with preventable hypoglycemia or DKA.

What to teach:

Site rotation: Rotate within one anatomical area systematically — don’t jump randomly between arm, abdomen, and thigh. Consistent rotation within one area (e.g., working across the abdomen in a grid) gives more predictable absorption. Inspect all injection sites regularly for lipohypertrophy (lumps, thickening) — if found, avoid that area and report to the provider.

Storage: Keep unopened insulin in the refrigerator (never freeze). In-use pens and vials can be at room temperature for 28 days (check the label). Keep insulin away from heat and sunlight — never leave it in a car in summer.

Hypoglycemia signs and response: Know the early warning signs: shakiness, sweating, rapid heartbeat, hunger, anxiety. Keep 15g fast-acting carbohydrates accessible at all times (juice, glucose tablets). Know the 15-15 rule. Always carry identification indicating insulin use. If living alone, consider a continuous glucose monitor (CGM).

When to call the provider:

• Blood glucose > 300 mg/dL on two consecutive readings
• Blood glucose persistently < 70 mg/dL despite treatment
• Symptoms of DKA: nausea, vomiting, fruity breath, deep rapid breathing, confusion
• Any new injection site infection: redness, warmth, swelling, drainage

Sick-day rules: Never skip insulin when sick — illness causes stress hormones that raise blood glucose even when not eating. Check BG more frequently (every 2–4 hours). Stay hydrated. If not keeping fluids down, call the provider promptly — illness plus vomiting plus no insulin intake is a fast track to DKA in type 1 diabetes.

Sharps disposal: Used needles and pen tips must go in an approved sharps container — never in the household trash. Most pharmacies provide sharps disposal services or mail-back programs.

Related resources

For broader clinical context, these nursing guides complement insulin administration:

• Diabetes mellitus nursing — pathophysiology, type 1 vs type 2, long-term complications, and the full clinical picture behind insulin therapy
• DKA nursing — diabetic ketoacidosis assessment, IV insulin protocol, and fluid resuscitation
• HHS nursing — hyperosmolar hyperglycemic state, the hyperglycemic emergency most common in type 2 diabetes
• Safe medication administration nursing — the 6 rights, independent double-checks, and high-alert medication protocols
• Medication rights nursing — the rights mnemonic in full, with NCLEX application
• Drug classifications nursing — insulin’s place within the broader antidiabetic drug class
• Vital signs by age — tachycardia and vital sign changes in hypoglycemia assessment